Sugammadex: routine use vs restrictive use.


Journal

British journal of hospital medicine (London, England : 2005)
ISSN: 1750-8460
Titre abrégé: Br J Hosp Med (Lond)
Pays: England
ID NLM: 101257109

Informations de publication

Date de publication:
02 Jun 2020
Historique:
pubmed: 27 6 2020
medline: 22 4 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Worldwide, the use of sugammadex for the reversal of neuromuscular blocking agents worldwide is restricted. This article reflects on how more liberal use of sugammadex might alter patient experience, anaesthetic delivery and surgical techniques.

Identifiants

pubmed: 32589529
doi: 10.12968/hmed.2020.0014
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Muscarinic Antagonists 0
Neuromuscular Nondepolarizing Agents 0
Atracurium 2GQ1IRY63P
Sugammadex 361LPM2T56
Neostigmine 3982TWQ96G
Glycopyrrolate V92SO9WP2I
Rocuronium WRE554RFEZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-2

Auteurs

Gloria Ashiru (G)

Department of Anaesthesia, Royal Free Hospital, London, UK.

Mark Carrington (M)

Department of Anaesthesia and Intensive Care, Royal Free Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH